KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Operating Expenses (2016 - 2026)

Johnson & Johnson's Operating Expenses history spans 18 years, with the latest figure at $9.6 billion for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 14.83% to $9.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $25.3 billion, a 36.43% decrease, with the full-year FY2025 number at $24.0 billion, down 40.47% from a year prior.
  • Operating Expenses hit $9.6 billion in Q1 2026 for Johnson & Johnson, up from -$3.5 billion in the prior quarter.
  • Over the last five years, Operating Expenses for JNJ hit a ceiling of $11.8 billion in Q4 2024 and a floor of -$10.6 billion in Q1 2022.
  • Historically, Operating Expenses has averaged $6.6 billion across 5 years, with a median of $9.1 billion in 2023.
  • Biggest five-year swings in Operating Expenses: crashed 261.96% in 2022 and later surged 377.09% in 2024.
  • Tracing JNJ's Operating Expenses over 5 years: stood at $8.5 billion in 2022, then crashed by 149.92% to -$4.3 billion in 2023, then soared by 377.09% to $11.8 billion in 2024, then tumbled by 129.4% to -$3.5 billion in 2025, then soared by 376.69% to $9.6 billion in 2026.
  • Business Quant data shows Operating Expenses for JNJ at $9.6 billion in Q1 2026, -$3.5 billion in Q4 2025, and $9.7 billion in Q3 2025.